WallStreetZenWallStreetZen

NASDAQ: GRI
Gri Bio Inc Stock

$0.51+0.00 (+0%)
Updated Apr 12, 2024
GRI Price
$0.51
Fair Value Price
N/A
Market Cap
$1.63M
52 Week Low
$0.50
52 Week High
$115.50
P/E
-0.02x
P/B
6.31x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$13.04M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
10.41
Operating Cash Flow
-$9M
Beta
0.83
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A

GRI Overview

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GRI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GRI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
GRI is poor value based on its book value relative to its share price (6.31x), compared to the US Biotechnology industry average (5.93x)
P/B vs Industry Valuation
GRI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more GRI due diligence checks available for Premium users.

Be the first to know about important GRI news, forecast changes, insider trades & much more!

GRI News

Valuation

GRI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.02x
Industry
14.72x
Market
42.64x

GRI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.31x
Industry
5.93x
GRI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GRI's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.0M
Profit Margin
0%
GRI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$3.0M
Liabilities
$2.7M
Debt to equity
10.41
GRI's short-term assets ($2.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GRI's short-term assets ($2.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GRI's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
GRI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.6M
Investing
$0.0
Financing
$3.9M
GRI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GRI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
GRI$1.63M+0.20%-0.02x6.31x
NBSE$1.64M+7.07%-0.06x0.18x
SPRC$1.74M-10.92%-0.40x0.83x
ATNF$1.84M-2.70%-0.04x-14.42x
VRAX$1.34M-5.13%-0.25x0.21x

Gri Bio Stock FAQ

What is Gri Bio's quote symbol?

(NASDAQ: GRI) Gri Bio trades on the NASDAQ under the ticker symbol GRI. Gri Bio stock quotes can also be displayed as NASDAQ: GRI.

If you're new to stock investing, here's how to buy Gri Bio stock.

What is the 52 week high and low for Gri Bio (NASDAQ: GRI)?

(NASDAQ: GRI) Gri Bio's 52-week high was $115.50, and its 52-week low was $0.50. It is currently -99.56% from its 52-week high and 1.59% from its 52-week low.

How much is Gri Bio stock worth today?

(NASDAQ: GRI) Gri Bio currently has 3,196,488 outstanding shares. With Gri Bio stock trading at $0.51 per share, the total value of Gri Bio stock (market capitalization) is $1.63M.

Gri Bio stock was originally listed at a price of $1,579.22 in Feb 10, 2021. If you had invested in Gri Bio stock at $1,579.22, your return over the last 3 years would have been -99.97%, for an annualized return of -93.13% (not including any dividends or dividend reinvestments).

How much is Gri Bio's stock price per share?

(NASDAQ: GRI) Gri Bio stock price per share is $0.51 today (as of Apr 12, 2024).

What is Gri Bio's Market Cap?

(NASDAQ: GRI) Gri Bio's market cap is $1.63M, as of Apr 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Gri Bio's market cap is calculated by multiplying GRI's current stock price of $0.51 by GRI's total outstanding shares of 3,196,488.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.